| 5.89 Data as of May 17 |  +0.20 / +3.51%Today’s Change | 3.00 Today|||52-Week Range 6.56 | +58.33% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Moore John R /array Biopharma/ Vice President & General Counsel |  Sale | 10/08/2012 | 26,190 | $5.69 | $149.0K | +6.03% |
Moore John R /array Biopharma/ Vice President & General Counsel | Sale | 4/23/2013 | 20,000 | $6.52 | $130.4K | -5.15% |
Moore John R /array Biopharma/ Vice President & General Counsel |  Buy | 4/23/2013 | 20,000 | $2.74 | $54.8K | -5.15% |
Moore John R /array Biopharma/ Vice President & General Counsel | Sale | 10/08/2012 | 2,357 | $5.69 | $13.4K | +6.03% |
Carruthers R Michael Chief Financial Officer | Gift | 10/04/2012 | 11,391 | $0.00 | $0.00 | -1.17% |
Koch Kevin President | Gift | 10/04/2012 | 22,718 | $0.00 | $0.00 | -1.17% |
Moore John R /array Biopharma/ Vice President & General Counsel | Gift | 10/04/2012 | 11,886 | $0.00 | $0.00 | -1.17% |
Snitman David L Chief Operating Officer & VP-Business Development | Gift | 10/04/2012 | 16,975 | $0.00 | $0.00 | -1.17% |
Squarer Ron Chief Executive Officer | Gift | 10/04/2012 | 4,397 | $0.00 | $0.00 | -1.17% |
Lefkoff Kyle A Director | Gift | 8/28/2012 | 1,000 | $0.00 | $0.00 | +0.17% |
.
